D. E. Shaw & Co. Inc. Buys 102,804 Shares of Teleflex Incorporated (NYSE:TFX)

D. E. Shaw & Co. Inc. grew its stake in shares of Teleflex Incorporated (NYSE:TFX) by 232.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 146,944 shares of the medical technology company’s stock after buying an additional 102,804 shares during the period. D. E. Shaw & Co. Inc. owned 0.32% of Teleflex worth $26,153,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Vontobel Holding Ltd. increased its position in shares of Teleflex by 21.9% during the fourth quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock valued at $248,000 after buying an additional 250 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock valued at $19,263,000 after buying an additional 5,322 shares during the period. Lecap Asset Management Ltd. purchased a new position in shares of Teleflex during the fourth quarter worth about $729,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Teleflex by 35.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock worth $1,053,000 after purchasing an additional 1,527 shares in the last quarter. Finally, Boston Trust Walden Corp grew its holdings in shares of Teleflex by 3.9% during the fourth quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company’s stock worth $52,435,000 after purchasing an additional 11,052 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Trading Down 0.9%

Teleflex stock opened at $125.10 on Monday. The business has a 50-day simple moving average of $133.86 and a two-hundred day simple moving average of $165.91. The company has a market cap of $5.53 billion, a P/E ratio of 24.87, a P/E/G ratio of 1.73 and a beta of 1.17. Teleflex Incorporated has a 52-week low of $120.06 and a 52-week high of $249.91. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same period in the previous year, the company posted $3.21 EPS. Analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.09%. Teleflex’s dividend payout ratio (DPR) is presently 42.90%.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on TFX. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Bank of America cut shares of Teleflex from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $235.00 to $140.00 in a research report on Tuesday, March 4th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Finally, Piper Sandler reiterated a “neutral” rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $164.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.